Psychopharmacology and Experimental Therapeutics for Bipolar Depression
Abstract
Abstract
Approach to Management of Bipolar Depression
Diagnostic Evaluation
First-Line Treatment for Bipolar Depression
Ongoing Assessments During the Course of Treatment
Non–FDA-Approved (Off-Label) Treatment Options for Bipolar Depression
Atypical Antipsychotics
Antidepressants
Ketamine
Medications Targeting Glutamatergic Neurotransmission (Other Than Ketamine)
Other Medications
Neurostimulation
Treatments Targeting Circadian Rhythm
Experimental Therapeutics for Bipolar Depression
Medications Targeting Monoamine Neurotransmission
Glutamatergic Medications
Anti-Inflammatory Medications
Neurostimulation
Other Treatments
Conclusion
Footnote
References
Information & Authors
Information
Published In
History
Keywords
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBLogin options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).